Adamis Pharmaceuticals Corporation Made Big Gain
Thu, Jun 03, 2021 at 05:30 PM
Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) shot up at $1.13, a gain of 61.4%. The stock got featured on our News Catalysts scanner on Tue, Jun 01, 2021 at 09:39 AM in the 'INVESTOR UPDATE' category. From Wed, May 19, 2021, the stock recorded 55.56% Up Days and 70.00% Green Days
The stock spiked on Mon, Mar 15, 2021 at $1.18 with a volume of 10M+, and its share price has been moving sideways in recent weeks.
About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Top 10 Gainers:
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 61.43%
- GTT Communications, Inc. (GTT:NYSE), 39.6%
- Energy Focus, Inc. (EFOI:NASDAQ), 35.43%
- The InterGroup Corporation (INTG:NASDAQ), 30.08%
- Workhorse Group Inc. (WKHS:NASDAQ), 28.21%
- Conn's, Inc. (CONN:NASDAQ), 27.32%
- Kindred Biosciences, Inc. (KIN:NASDAQ), 23.71%
- PYR (PYR:NASDAQ), 23.35%
- SemiLEDs Corporation (LEDS:NASDAQ), 23.27%
- Q&K International Group Limited (QK:NASDAQ), 22.95%